Misleading ADHD and Autism Ads: CAP Flags Over 1,300 Violations

Significant Findings on Misleading Advertisements

The Committee of Advertising Practice (CAP) has conducted a thorough review of advertisements between February and July 2026, uncovering a total of 1,383 ads that violated established advertising guidelines. This evaluation was part of a larger initiative where CAP identified 72,400 relevant ads and reviewed 1,595 from 17 different advertisers.

Urgent Need for Compliance in Advertising

According to Isabel Lucas, CAP's compliance executive, the purpose of this enforcement report is to protect vulnerable populations, especially parents and individuals seeking help for ADHD or autism traits. The CAP's goal is to eliminate deceptive ads that claim supplements can treat or cure these conditions. "A successful outcome is when misleading advertisements are no longer displayed to those who need genuine support," she stated.

Monitoring and Actions Taken

This initiative was prompted by five rulings from the Advertising Standards Authority (ASA) in December 2025, which addressed unauthorized advertising claims on social media platforms like Meta and search engines like Google. According to Lucas, the challenge lies in the rapid growth of online advertising and the ease with which new advertisers can enter the supplements market. "New advertisers can appear almost instantaneously, complicating enforcement efforts," she explained.

After being contacted by CAP, 11 advertisers agreed to either remove or adjust their advertisements. Notably, two companies removed their ads without any engagement, and Meta took down one advertiser's advertisements altogether.

Challenges with Compliance

Lucas highlighted that many of the contacted advertisers operated outside the UK and may not fully understand local advertising regulations. While the actions taken have successfully reduced harmful advertising, the overall compliance rate remains concerningly low. "The vulnerable nature of these audiences, along with low compliance, signifies that we must persist in our intervention efforts," Lucas observed.

The Nuances of Nutrition and Neurodevelopment

ADHD impacts individuals in the realms of attention, impulse control, and activity levels, whereas autism influences social communication and sensory experiences. Although there is a rising interest in supplements like omega-3 fatty acids and probiotics as potential adjuncts in ADHD treatment, the scientific support for these claims is conflicted.

Dr. Miguel Toribio-Mateas, a clinical neuroscientist and nutrition researcher at the University of West London, emphasized the report's importance amid growing commercial interest in nutritional approaches for neuro-developmental conditions. He cautioned that while there is credible scientific curiosity about nutrition's effects on brain function, mere positive findings from a few studies do not provide sufficient grounds for making effective health claims.

The Misconception of Neurodivergence

Dr. Toribio-Mateas expressed concern that such advertisements perpetuate harmful beliefs that neurodivergent individuals require modifications. He asserted, "Advertisements that promise to diminish symptoms of ADHD or autism can foster the damaging perception that neurodivergent people need to be 'fixed.' Care and nutritional support should always reflect individual goals and needs rather than assumptions about necessary changes to neurodiversity."

Future Directions for the Supplement Industry

Dr. Toribio-Mateas also noted that the supplement sector has the potential to positively influence the health of neurodivergent individuals, provided they prioritize high-quality research, appropriate claims, and clear communication. By maintaining transparency, the industry can foster a more supportive environment for those navigating ADHD and autism challenges.